Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience
Identifieur interne : 00E350 ( Main/Exploration ); précédent : 00E349; suivant : 00E351Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience
Auteurs : Lawrence J. Solin [États-Unis] ; Barbara Fowble [États-Unis] ; Karen L. Martz [États-Unis] ; Robert L. Goodman [États-Unis]Source :
- International Journal of Radiation Oncology, Biology, Physics [ 0360-3016 ] ; 1988.
Abstract
From 1977 to 1984, 552 breast cancers in 548 women were treated with definitive irradiation following breast-conserving surgery at the Hospital of the University of Pennsylvania and the Fox Chase Cancer Center. All patients had invasive carcinoma and were AJC clinical Stage I or 11. Pathologic axillary lymph node staging was known for all cases. The 5-year actuarial survival for the entire group was 93% with an NED survival of 81%. The 5-year survival for clinical Stage I and 11 patients was 97 and 87%, respectively, with a corresponding NED survival of 87 and 73%, respectively. For pathologic Stage I and II patients, the corresponding survival figures were 97 and 89%, respectively, with NED survival rates of 86 and 76%, respectively. The overall 5-year actuarial local failure rate was 6%, and the rate of local only as the first failure was 3%. The overall local-regional failure rate was 13% with a local-regional only first failure rate of 8%. These results compare favorably with other reported series and contribute a substantial number of patients to the increasing experience with definitive irradiation following breast-conserving procedures. The relatively low incidence of breast recurrence may be related to the emphasis on integrating the surgical, pathologic, and radiotherapeutic aspects of treatment, as well as the emergence of a re-excision policy for patients at high risk to have residual tumor.
Url:
DOI: 10.1016/0360-3016(88)90426-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B39
- to stream Istex, to step Curation: 001B39
- to stream Istex, to step Checkpoint: 005911
- to stream Main, to step Merge: 00F040
- to stream Main, to step Curation: 00E350
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience</title><author><name sortKey="Solin, Lawrence J" sort="Solin, Lawrence J" uniqKey="Solin L" first="Lawrence J." last="Solin">Lawrence J. Solin</name></author><author><name sortKey="Fowble, Barbara" sort="Fowble, Barbara" uniqKey="Fowble B" first="Barbara" last="Fowble">Barbara Fowble</name></author><author><name sortKey="Martz, Karen L" sort="Martz, Karen L" uniqKey="Martz K" first="Karen L." last="Martz">Karen L. Martz</name></author><author><name sortKey="Goodman, Robert L" sort="Goodman, Robert L" uniqKey="Goodman R" first="Robert L." last="Goodman">Robert L. Goodman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3C2232D99290567B664A7F64BED63BD10ABA81AF</idno><date when="1988" year="1988">1988</date><idno type="doi">10.1016/0360-3016(88)90426-9</idno><idno type="url">https://api.istex.fr/document/3C2232D99290567B664A7F64BED63BD10ABA81AF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B39</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B39</idno><idno type="wicri:Area/Istex/Curation">001B39</idno><idno type="wicri:Area/Istex/Checkpoint">005911</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">005911</idno><idno type="wicri:doubleKey">0360-3016:1988:Solin L:definitive:irradiation:for</idno><idno type="wicri:Area/Main/Merge">00F040</idno><idno type="wicri:Area/Main/Curation">00E350</idno><idno type="wicri:Area/Main/Exploration">00E350</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience</title><author><name sortKey="Solin, Lawrence J" sort="Solin, Lawrence J" uniqKey="Solin L" first="Lawrence J." last="Solin">Lawrence J. Solin</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Therapy, University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:regionArea><wicri:noRegion>University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:noRegion></affiliation></author><author><name sortKey="Fowble, Barbara" sort="Fowble, Barbara" uniqKey="Fowble B" first="Barbara" last="Fowble">Barbara Fowble</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Therapy, University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:regionArea><wicri:noRegion>University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:noRegion></affiliation></author><author><name sortKey="Martz, Karen L" sort="Martz, Karen L" uniqKey="Martz K" first="Karen L." last="Martz">Karen L. Martz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Statistical Unit, American College of Radiology, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Goodman, Robert L" sort="Goodman, Robert L" uniqKey="Goodman R" first="Robert L." last="Goodman">Robert L. Goodman</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Therapy, University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:regionArea><wicri:noRegion>University of Pennsylvania School of Medicine and The Fox Chase Cancer Center</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">International Journal of Radiation Oncology, Biology, Physics</title><title level="j" type="abbrev">ROB</title><idno type="ISSN">0360-3016</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1988">1988</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="235">235</biblScope><biblScope unit="page" to="242">242</biblScope></imprint><idno type="ISSN">0360-3016</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0360-3016</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">From 1977 to 1984, 552 breast cancers in 548 women were treated with definitive irradiation following breast-conserving surgery at the Hospital of the University of Pennsylvania and the Fox Chase Cancer Center. All patients had invasive carcinoma and were AJC clinical Stage I or 11. Pathologic axillary lymph node staging was known for all cases. The 5-year actuarial survival for the entire group was 93% with an NED survival of 81%. The 5-year survival for clinical Stage I and 11 patients was 97 and 87%, respectively, with a corresponding NED survival of 87 and 73%, respectively. For pathologic Stage I and II patients, the corresponding survival figures were 97 and 89%, respectively, with NED survival rates of 86 and 76%, respectively. The overall 5-year actuarial local failure rate was 6%, and the rate of local only as the first failure was 3%. The overall local-regional failure rate was 13% with a local-regional only first failure rate of 8%. These results compare favorably with other reported series and contribute a substantial number of patients to the increasing experience with definitive irradiation following breast-conserving procedures. The relatively low incidence of breast recurrence may be related to the emphasis on integrating the surgical, pathologic, and radiotherapeutic aspects of treatment, as well as the emergence of a re-excision policy for patients at high risk to have residual tumor.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><noRegion><name sortKey="Solin, Lawrence J" sort="Solin, Lawrence J" uniqKey="Solin L" first="Lawrence J." last="Solin">Lawrence J. Solin</name></noRegion><name sortKey="Fowble, Barbara" sort="Fowble, Barbara" uniqKey="Fowble B" first="Barbara" last="Fowble">Barbara Fowble</name><name sortKey="Goodman, Robert L" sort="Goodman, Robert L" uniqKey="Goodman R" first="Robert L." last="Goodman">Robert L. Goodman</name><name sortKey="Martz, Karen L" sort="Martz, Karen L" uniqKey="Martz K" first="Karen L." last="Martz">Karen L. Martz</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00E350 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00E350 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3C2232D99290567B664A7F64BED63BD10ABA81AF
|texte= Definitive irradiation for early stage breast cancer: The University of Pennsylvania experience
}}
| This area was generated with Dilib version V0.6.31. |  |